vs
STANDARD BIOTOOLS INC.（LAB）与PROVIDENT FINANCIAL HOLDINGS INC（PROV）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是PROVIDENT FINANCIAL HOLDINGS INC的2.0倍（$19.6M vs $9.8M），PROVIDENT FINANCIAL HOLDINGS INC净利率更高（14.6% vs -177.4%，领先192.0%），PROVIDENT FINANCIAL HOLDINGS INC同比增速更快（2.5% vs -11.5%），PROVIDENT FINANCIAL HOLDINGS INC自由现金流更多（$1.0M vs $-23.1M），过去两年PROVIDENT FINANCIAL HOLDINGS INC的营收复合增速更高（2.3% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
普罗维登特金融控股公司是一家银行控股企业，通过旗下全资子公司普罗维登特储蓄银行开展业务，为美国加利福尼亚州当地社区提供各类存款、住房抵押贷款、消费贷款、小微企业融资等零售及商业金融服务。
LAB vs PROV — 直观对比
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $9.8M |
| 净利润 | $-34.7M | $1.4M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 20.8% |
| 净利率 | -177.4% | 14.6% |
| 营收同比 | -11.5% | 2.5% |
| 净利润同比 | -28.8% | 64.7% |
| 每股收益（稀释后） | $-0.09 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $9.8M | ||
| Q3 25 | $19.6M | $9.7M | ||
| Q2 25 | $21.8M | $9.8M | ||
| Q1 25 | $40.8M | $10.1M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | $22.1M | $9.5M | ||
| Q2 24 | $22.5M | $9.9M | ||
| Q1 24 | $45.5M | $9.4M |
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-34.7M | $1.7M | ||
| Q2 25 | $-33.5M | $1.6M | ||
| Q1 25 | $-26.0M | $1.9M | ||
| Q4 24 | — | $872.0K | ||
| Q3 24 | $-26.9M | $1.9M | ||
| Q2 24 | $-45.7M | $2.0M | ||
| Q1 24 | $-32.2M | $1.5M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 20.8% | ||
| Q3 25 | -168.5% | 28.1% | ||
| Q2 25 | -118.1% | 23.6% | ||
| Q1 25 | -80.8% | 26.2% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | -120.9% | 28.3% | ||
| Q2 24 | -134.5% | 27.8% | ||
| Q1 24 | -132.2% | 22.5% |
| Q4 25 | — | 14.6% | ||
| Q3 25 | -177.4% | 17.3% | ||
| Q2 25 | -153.7% | 16.7% | ||
| Q1 25 | -63.8% | 18.4% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | -122.0% | 20.0% | ||
| Q2 24 | -203.3% | 19.7% | ||
| Q1 24 | -70.6% | 15.9% |
| Q4 25 | — | $0.22 | ||
| Q3 25 | $-0.09 | $0.25 | ||
| Q2 25 | $-0.09 | $0.24 | ||
| Q1 25 | $-0.07 | $0.28 | ||
| Q4 24 | — | $0.13 | ||
| Q3 24 | $-0.07 | $0.28 | ||
| Q2 24 | $-0.12 | $0.28 | ||
| Q1 24 | $-0.27 | $0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $54.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $127.5M |
| 总资产 | $539.6M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $54.4M | ||
| Q3 25 | $129.4M | $49.4M | ||
| Q2 25 | $158.6M | $53.1M | ||
| Q1 25 | $150.9M | $50.9M | ||
| Q4 24 | — | $45.5M | ||
| Q3 24 | $210.6M | $48.2M | ||
| Q2 24 | $269.8M | $51.4M | ||
| Q1 24 | $287.1M | $51.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $127.5M | ||
| Q3 25 | $399.7M | $128.4M | ||
| Q2 25 | $424.5M | $128.5M | ||
| Q1 25 | $454.6M | $128.9M | ||
| Q4 24 | — | $128.6M | ||
| Q3 24 | $489.3M | $129.6M | ||
| Q2 24 | $510.3M | $129.9M | ||
| Q1 24 | $577.3M | $129.5M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $539.6M | $1.2B | ||
| Q2 25 | $557.0M | $1.2B | ||
| Q1 25 | $579.6M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $681.5M | $1.3B | ||
| Q2 24 | $708.7M | $1.3B | ||
| Q1 24 | $777.7M | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $1.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $1.0M |
| 自由现金流率自由现金流/营收 | -118.1% | 10.5% |
| 资本支出强度资本支出/营收 | 4.5% | 1.9% |
| 现金转化率经营现金流/净利润 | — | 0.85× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $14.9M |
8季度趋势，按日历期对齐
| Q4 25 | — | $1.2M | ||
| Q3 25 | $-22.2M | $2.5M | ||
| Q2 25 | $-20.7M | $8.7M | ||
| Q1 25 | $-30.3M | $3.3M | ||
| Q4 24 | — | $324.0K | ||
| Q3 24 | $-27.9M | $2.6M | ||
| Q2 24 | $-39.0M | $5.7M | ||
| Q1 24 | $-62.5M | $3.0M |
| Q4 25 | — | $1.0M | ||
| Q3 25 | $-23.1M | $2.5M | ||
| Q2 25 | $-22.6M | $8.2M | ||
| Q1 25 | $-35.3M | $3.3M | ||
| Q4 24 | — | $307.0K | ||
| Q3 24 | $-30.1M | $2.4M | ||
| Q2 24 | $-41.0M | $4.1M | ||
| Q1 24 | $-63.3M | $2.6M |
| Q4 25 | — | 10.5% | ||
| Q3 25 | -118.1% | 25.2% | ||
| Q2 25 | -103.6% | 83.5% | ||
| Q1 25 | -86.6% | 32.5% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | -136.4% | 25.1% | ||
| Q2 24 | -182.2% | 41.3% | ||
| Q1 24 | -138.9% | 27.5% |
| Q4 25 | — | 1.9% | ||
| Q3 25 | 4.5% | 0.5% | ||
| Q2 25 | 8.7% | 5.4% | ||
| Q1 25 | 12.4% | 0.3% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 10.2% | 1.8% | ||
| Q2 24 | 8.6% | 16.0% | ||
| Q1 24 | 1.7% | 4.2% |
| Q4 25 | — | 0.85× | ||
| Q3 25 | — | 1.48× | ||
| Q2 25 | — | 5.34× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | 0.37× | ||
| Q3 24 | — | 1.35× | ||
| Q2 24 | — | 2.91× | ||
| Q1 24 | — | 2.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
PROV
暂无分部数据
